Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY19 is not expected to be complete until June, 2020.

  1. Biphase Extended Release Tablet Formulation for Nerve Agent Pretreatment

    SBC: Zymeron Corporation            Topic: CBD181004

    Given the unforeseen/unanticipated use of nerve agents in the battlefield and on the homeland, military personnel can benefit from this oncedaily pretreatment. It may also be desirable to pretreat certain medical and emergency aid personnel following a known/suspected nerveagent attack. Also, a novel, improved PB extended release formulations can be commercialized for the treatment of myasthenia g ...

    SBIR Phase I 2019 Department of DefenseOffice for Chemical and Biological Defense
  2. HIGH STRETCH, ENVIRONMENTALLY ROBUST HYBRIDSIL PERFLUOROELASTOMER BARRIERCOMPOSITES FOR CBRN PROTECTIVE ENSEMBLES

    SBC: Nanosonic Inc.            Topic: CBD181003

    Through the proposed SBIR program, NanoSonic will design, empirically validate, and commercially transition durable, high stretch HybridSilbarrier composites for next-generation CBRN protective ensembles. NanoSonic's durable HybridSil stretch barrier composites will bemolecularly designed and empirically optimized to provide a previously unavailable combination of biaxial isotropic stretch for wea ...

    SBIR Phase I 2019 Department of DefenseOffice for Chemical and Biological Defense
  3. Point of Care Test for Disease Severity and Risk Stratification

    SBC: Lynntech Inc.            Topic: DHA172008

    Lynntech will design and build a prototype scale reduced weight, environmentally stable, CBC device which is usable at Roles 2 and higher which requires no cold chain storage. The device is specifically intended to be used by medical personnel deployed in Health Response Teams (HRTs) who are not lab technicians and who do not have rapid, reliable access to a hematology lab. To this end, the soluti ...

    SBIR Phase II 2019 Department of DefenseDefense Health Program
  4. WEARABLE WARFIGHTER HEALTH MONITORING SYSTEM

    SBC: TIGER TECH SOLUTIONS INC            Topic: DHA172010

    Tiger Tech Solutions, Inc. has developed a unique professional quality biomedical wearable monitoring system. The consumer-oriented devices available on the market today are not suitable for the needs of the warfighter. The Tiger Tech Warfighter Monitor (WFM) is a hands-free, continuous, real-time, and multi-vital wrist wearable that accurately monitors an individuals biometrics. The WFM is a high ...

    SBIR Phase II 2019 Department of DefenseDefense Health Program
  5. Mobile Causality Display Toolkit for Tactical Combat Casualty Care

    SBC: QUANTIFIED DESIGN SOLUTIONS, LLC            Topic: DHA172006

    The high rate of non-medical Soldiers (Combat Lifesavers and self-aid/buddy-aid) performing field care necessitates additional medical training for those Warfighters. Unfortunately, most non-medical personnel are not provided with opportunities to practice medical skills in a high stress environment prior to completing them during live missions due to a lack of access to ruggedized high fidelity t ...

    SBIR Phase II 2019 Department of DefenseDefense Health Program
  6. Next-Generation Ear Seals for Circumaural Headsets and Hearing Protectors

    SBC: Oceanit Laboratories, Inc.            Topic: DHA172007

    Service members are exposed to high noise environments on a daily basis. Aviation, mechanized, light and armored units are all exposed to environments well in excess of the permissible noise levels. In aviation alone, flight crews spend a majority of their day in aircraft and, even when not flying, are still subjected to the high noise levels of an active airfield. Ground crews carry headsets with ...

    SBIR Phase II 2019 Department of DefenseDefense Health Program
  7. Rapid At-home Test for Monitoring Tacrolimus Levels in Plasma

    SBC: Lynntech Inc.            Topic: A18145

    Vascularized composite allotransplantation (VCA) is a surgical approach for the clinical management of non-salvagable injuries. Tissue rejection is a major issue for patients receiving VCA. Tacrolimus is the most common immunosuppressant employed to minimize tissue rejections in VCA. The safety and efficacy of tacrolimus, which has a narrow therapeutic window is particularly sensitive to proper ma ...

    SBIR Phase I 2019 Department of DefenseDefense Health Program
  8. Complex Crystalloid Resuscitative Fluid

    SBC: GanD Inc            Topic: DHA172009

    Problem: Currently available resuscitation fluids have been shown to induce detrimental effects on trauma outcomes.Objective: The objective of this proposal is to use the data from the successful Phase 1 studies to guide the continued development and testing of the novel resuscitation fluid (GND-001), which has been designed to address the deficiencies of current resuscitation fluids.Proposed work ...

    SBIR Phase II 2019 Department of DefenseDefense Health Program
  9. Advanced Manufacturing and Material Measurements Software Tool Weave ™ for the Acceleration and Automation of SEM Image Analysis in the Semiconductor Industry

    SBC: Sandbox Semiconductor Incorporated            Topic: None

    In this Phase I SBIR proposal, SandBox Semiconductor™ proposes to develop an Advanced Manufacturing and Material Measurements software tool called Weave ™ for accelerating and automating SEM image analysis for the semiconductor industry. During the development of a new manufacturing process line for a semiconductor device, tens of thousands of scanning electron microscopy (SEM) images are take ...

    SBIR Phase I 2019 Department of CommerceNational Institute of Standards and Technology
  10. Microcapillary Quartz Sensors for Screening Injectability of High Concentration Protein Formulations

    SBC: Qatch Technologies, LLC            Topic: None

    The objective of this SBIR Phase I proposal is to determine the feasibility of viscosity characterization of high concentration protein formulations (HCF) by QATCH’s microcapillary quartz technology. HCFs are non-Newtonian fluids with shear-thinning behavior and they are administered to patients by subcutaneous or muscular injections. The injectability of HCFs depends on the viscosity at high-sh ...

    SBIR Phase I 2019 Department of CommerceNational Institute of Standards and Technology
US Flag An Official Website of the United States Government